+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
MAXHEALTH

Max Healthcare Institute Share Price

 

 

Max Healthcare Institute live price: ₹1012.45. It opened at ₹1,018 vs previous close ₹1,010; intraday high/low: ₹1,018/₹1,008. The 50 & 200 DMA stand at ₹1,005.91/₹1,049.24.

Max Healthcare Institute Performance

  • Today's Low
  • ₹1,008
  • Today's High
  • ₹1,018
  • 52 Week Low
  • ₹903
  • 52 Week High
  • ₹1,314
  • Open Price₹1,018
  • Previous Close₹1,010
  • Volume760,456
  • 50 DMA₹1,005.91
  • 100 DMA₹1,021.58
  • 200 DMA₹1,049.24

Max Healthcare Institute Chart

Investment Returns

  • Over 1 Month -2.46%
  • Over 3 Month -1.91%
  • Over 6 Month -6.94%
  • Over 1 Year -14.71%

Smart Investing Starts Here Start SIP with Max Healthcare Institute for Steady Growth!

Invest Now

Max Healthcare Institute Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 68.3
  • PEG Ratio
  • 2
  • Market Cap Cr
  • 98,536
  • P/B Ratio
  • 9.2
  • Average True Range
  • 27.34
  • EPS
  • 15.25
  • Dividend Yield
  • 0.1
  • MACD Signal
  • -5.69
  • RSI
  • 53.16
  • MFI
  • 34.69

Latest Stock News Updates

Max Healthcare Institute Results Earnings Call for Q4FY26 & Full Year

Conference Call with Max Healthcare Institute Management and Analysts on Q4FY26 & Full Year Performance and Outlook. Listen to the full earnings transcript.

Max Healthcare falls 7% on Q4 results; profit rises 7% amid margin pressure

Max Healthcare reported a consolidated revenue from operations of 2,142.89 crore, up 12.2 per cent from 1,909.74 crore in the year-ago period

Q4FY26 & FY26 Result Announced for Max Healthcare Institute Ltd.

Healthcare Facilities company Max Healthcare Institute announced Q4FY26 & FY26 results Consolidated Financial Highlights: Total Income: For Q4FY26, the total income was reported at Rs 2,19,072 lakh, representing a QoQ increase of 3.68% from Rs 2,11,290 lakh in Q3FY26 and a YoY increase of 11.96% from Rs 1,95,666 lakh in Q4FY25. For the full financial year FY26, total income stood at Rs 8,53,607 lakh, up by 18.82% compared to Rs 7,18,410 lakh in FY25. Revenue from Operations: Stood at Rs 2,14,289 lakh for Q4FY26, compared to Rs 2,06,752 lakh in Q3FY26 (up 3.65% QoQ) and Rs 1,90,974 lakh in Q4FY25 (up 12.21% YoY). For FY26, it reached Rs 8,37,345 lakh against Rs 7,02,846 lakh in FY25. Net Profit After Tax: Reported at Rs 34,222 lakh for Q4FY26, showing a QoQ growth of 13.72% from Rs 30,092 lakh in Q3FY26 and a YoY increase of 7.28% from Rs 31,900 lakh in Q4FY25. For FY26, the profit for the year was Rs 1,44,241 lakh, an increase of 34.07% YoY from Rs 1,07,588 lakh in FY25. Standalone Financial Highlights: Total Income: For Q4FY26, the total income was Rs 82,424 lakh, reflecting a QoQ increase of 3.78% from Rs 79,424 lakh in Q3FY26 and a YoY increase of 8.90% from Rs 75,685 lakh in Q4FY25. For FY26, the total income was Rs 3,17,640 lakh, up by 4.83% from Rs 3,03,014 lakh in FY25. Revenue from Operations: Stood at Rs 73,290 lakh for Q4FY26, an increase of 3.09% QoQ from Rs 71,091 lakh in Q3FY26 and an increase of 11.26% YoY from Rs 65,870 lakh in Q4FY25. For FY26, it stood at Rs 2,87,445 lakh against Rs 2,66,360 lakh in FY25. Net Profit After Tax: Reported at Rs 20,321 lakh for Q4FY26, up 8.70% QoQ from Rs 18,695 lakh in Q3FY26 and up 14.56% YoY from Rs 17,739 lakh in Q4FY25. For FY26, net profit reached Rs 71,661 lakh, up 2.22% YoY from Rs 70,107 lakh in FY25. Business Highlights: Segment Performance: The Group's business activity primarily falls within a single reportable business segment, namely 'Medical and Healthcare Services', and a single geographical segment, 'India'. Strategic Acquisition: On May 18, 2026, the Company acquired a 58.28% controlling equity stake in Kalinga Hospitals Limited (KHL), which owns and operates a 250-bed multi-specialty hospital in Bhubaneswar, Odisha, for an aggregate cash consideration of Rs 29,797 lakh. Expansion Project: The Board approved the construction of Phase-I of Max Super Specialty Hospital at Shaheed Path, Lucknow, on a 5-acre land parcel. The project will accommodate approximately 712 census beds with an expected total construction and equipment cost of ~Rs 1,400 crore (blended cost per bed of ~Rs 1.97 crore, excluding land). Dividend: The Board recommended a final dividend of Rs 2/- per equity share (20% of face value of Rs 10/- each) for the financial year 2025-26, subject to member approval. Corporate Restructuring and Re-classification: The Company approved the re-classification of Radiant Life Care Hospital Foundation from the ‘Promoter Group’ to the ‘Public’ category. Additionally, the merger of erstwhile Jaypee Healthcare Limited (JHL) and erstwhile Crosslay Remedies Limited (CRL) became effective from December 15, 2025. Exceptional Items: Consolidated results for FY26 included a non-recurring impact of Rs 3,390 lakh due to the notification of new Labour Codes and a provision for stamp duty on merger amounting to Rs 1,434 lakh. Standalone results included an exceptional impact of Rs 1,564 lakh related to the new Labour Codes. Operational Shift: The Board approved shifting the Company’s registered office from the State of Maharashtra to Gurugram, Haryana. Voluntary Liquidation: The Company initiated the voluntary liquidation of its non-material wholly-owned subsidiary, MHC Global Healthcare (Nigeria) Limited Abhay Soi, Chairman & Managing Director, Max Healthcare Institute, said: “We are pleased to announce the phased commissioning and ramp-up of brownfield expansions across Mohali, Mumbai and Delhi, representing approximately 20% capacity addition. We also look forward to augmenting our capacity by another ~10% with the commissioning of the greenfield Gurgaon facility by the end of the year. We are also happy that the Network has delivered its 22nd consecutive quarter of year-on-year growth, with revenue increasing by 10% and operating EBITDA grew by 8%. Further, we have completed the acquisition of a controlling stake in Kalinga Hospital, Bhubaneswar. The team has already begun integration and is working towards achieving significant operational upside. In parallel, work has commenced on the upgradation and expansion of the hospital, enabling us to extend high-quality healthcare services in a fast-growing region.” Result PDF

Max Healthcare Institute Financials

Max Healthcare Institute Technicals

EMA & SMA

Current Price
₹1,012.45
+ 2.85 (0.28%)
pointer
  • Bearish Moving Average 4
  • Bullish Moving Average 12
  • 20 Day
  • ₹1,000.90
  • 50 Day
  • ₹1,005.90
  • 100 Day
  • ₹1,021.60
  • 200 Day
  • ₹1,049.20

Resistance and Support

1012.92 Pivot Speed
  • R3 1,027.23
  • R2 1,022.62
  • R1 1,017.53
  • S1 1,007.83
  • S2 1,003.22
  • S3 998.13

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Max Healthcare Institute Ltd. is one of India’s leading healthcare providers, operating a network of multi-specialty hospitals. It offers comprehensive medical services across various specialties, including oncology, cardiology, and neurology, serving both domestic and international patients.

Max Healthcare Institute has an operating revenue of Rs. 8,373.45 Cr. on a trailing 12-month basis. An annual revenue growth of 19% is outstanding, Pre-tax margin of 20% is great, ROE of 13% is good. The company has a reasonable debt to equity of 28%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 23% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 79 which is a FAIR score but needs to improve its earnings, a RS Rating of 44 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 46 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Max Healthcare Institute Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-21 Audited Results & Final Dividend
2026-02-05 Quarterly Results
2025-11-14 Quarterly Results
2025-08-13 Quarterly Results
2025-05-20 Audited Results & Final Dividend
Date Purpose Remarks
2025-07-04 FINAL Rs.1.50 per share(15%)Final Dividend
2024-08-23 FINAL Rs.1.50 per share(15%)Final Dividend
2023-09-08 FINAL Rs.1.00 per share(10%)Final Dividend
View Max Healthcare Institute Dividend History Arrow

Max Healthcare Institute F&O

Max Healthcare Institute Shareholding Pattern

23.71%
16.3%
6.31%
45.39%
0.13%
3.27%
4.89%

Max Healthcare Institute FAQs

Max Healthcare Institute share price is ₹1,012 As on 13 June, 2026 | 01:25

The Market Cap of Max Healthcare Institute is ₹98536.1 Cr As on 13 June, 2026 | 01:25

The P/E ratio of Max Healthcare Institute is 68.3 As on 13 June, 2026 | 01:25

The PB ratio of Max Healthcare Institute is 9.2 As on 13 June, 2026 | 01:25

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23